Diana Hausman - Jun 14, 2023 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
Stock symbol
IMRX
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 04:39 PM
Previous filing
May 10, 2023
Next filing
Feb 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +17.5K $0.00 17.5K Jun 14, 2023 Class A Common Stock 17.5K $9.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in substantially equal monthly installments over a one-year period with a vesting commencement date of June 14, 2023, and will be fully vested and exercisable on June 14, 2024, or the date of the 2024 annual meeting of stockholders, whichever comes first.